Cargando…
The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
PURPOSE: To explore the impact of coronavirus disease 2019 (COVID-19) on the prognosis of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV), and share the experience in managing them during pandemics. METHOD: This is a retrospective study o...
Autores principales: | Zhao, Xinyu, Meng, Lihui, Luo, Mingyue, Yu, Weihong, Min, Hanyi, Dai, Rongping, Koh, Adrian, Chen, Youxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221678/ https://www.ncbi.nlm.nih.gov/pubmed/34221305 http://dx.doi.org/10.1177/20406223211026389 |
Ejemplares similares
-
Comparison of choriocapillary flow density between fellow eyes of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration
por: Luo, Mingyue, et al.
Publicado: (2020) -
Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients
por: Zhou, Huiying, et al.
Publicado: (2020) -
SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Kondo, Naoshi, et al.
Publicado: (2009) -
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
por: Nishikawa, Keiichi, et al.
Publicado: (2019) -
Evaluation of the association of C5 with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Liu, Ke, et al.
Publicado: (2019)